Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity

Journal of Clinical Investigation

Volumn 115, Issue 1, 2005, Pages 66-75

  Smythies, Lesley E ^a   Sellers, Marty ^b   Clements, Ronald H ^b   Mosteller Barnum, Meg ^a   Meng, Gang ^a   Benjamin, William H ^c   Orenstein, Jan M ^d   Smith, Phillip D ^a,e  

^a University of Alabama at Birmingham   (United States)

^b Kentucky   (United States)

^c University of Alabama at Birmingham   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^e BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD123 ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD18 ANTIGEN; CD32 ANTIGEN; CD64 ANTIGEN; CD89 ANTIGEN; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; FC RECEPTOR; GLYCOPROTEIN P 15095; GROWTH FACTOR RECEPTOR; INTEGRIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 3; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LYMPHOCYTE ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; RANTES; RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; MEMBRANE ANTIGEN;

ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GASTROINTESTINAL MUCOSA; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; INFLAMMATION; INTESTINAL MACROPHAGE; MACROPHAGE; MONOCYTE; NONHUMAN; NORMAL HUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; STROMA CELL; CHEMISTRY; CULTURE MEDIUM; DOWN REGULATION; DRUG EFFECT; ESCHERICHIA COLI; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; JEJUNUM; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; SALMONELLA TYPHIMURIUM;

ANTIGENS, SURFACE; CULTURE MEDIA, CONDITIONED; CYTOKINES; DOWN-REGULATION; ESCHERICHIA COLI; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; JEJUNUM; LIPOPOLYSACCHARIDES; MACROPHAGES; PHAGOCYTOSIS; PHENOTYPE; SALMONELLA TYPHIMURIUM; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 13744256812     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200519229     Document Type: Article

References (44)

1. Lee, S.H., Starkey, P.M., and Gordon, S. 1985. Quantitative analysis of total macrophage content in adult mouse tissues: Immunochemical studies with monoclonal Ab F4/80. J. Exp. Med. 161:475-489.
2. Brandtzaeg, P. 1989. Overview of the mucosal immune system. Curr. Top. Microbiol. Immunol. 146:13-25.
3. Ulevitch, R.J., and Tobias, P.S. 1995. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Ann. Rev. Immunol. 13:437-457.
4. Smith, P.D., et al. 1997. Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine. J. Immunol. Meth. 202:1-11.
5. Smith, P.D., et al. 2001. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J. Immunol. 167:2651-2656.
6. + population of monocytes in inflammatory bowel disease mucosa - implications for pathogenesis. Clin. Exp. Immunol. 100:291-297.
7. Rogler, G., et al. 1998. Isolation and phenotypic characterization of colonic macrophages. Clin. Exp. Immunol. 112:205-215.
8. Herzyk, D.J., Allen, J.N., Marsh, C.B., and Wewers, M.D. 1992. Macrophage and monocyte IL-1β regulation differs at multiple sites. Messenger RNA expression, translation, and post-translational processing. J. Immunol. 149:3052-3058.
9. Rugtveit, J., Brandtzaeg, P., Halstensen, T.S., Fausa, O., and Scott, H. 1994. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut. 35:669-674.
10. Harris, P.R., Mobley, H.L., Perez-Perez, G.I., Blaser, M.J., and Smith, P.D. 1996. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology. 111:419-425.
11. Mai, U.E., et al. 1991. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J. Clin. Invest. 87:894-900.
12. Smith, P.D., Smythies, L.E., and Wahl, S.M. 2001. Macrophage effector function. In Clinical immunology. R.R. Rich, T.A. Fleisher, W.T. Sherarer, B. Kotzin, and H.W.J. Schroeder, editors. Harcourt Health Sciences. London, United Kingdom. 19.11-19.19.
13. Finlay, B.B., and Cossart, P. 1997. Exploitation of mammalian host cell functions by bacterial pathogens. Science. 276:718-725.
14. Tsunawaki, S., Sporn, M.B., Ding, A., and Nathan, C. 1988. Deactivation of macrophages by transforming growth factor-β. Nature. 334:260-262.
15. Wahl, S.M. 1994. Transforming growth factor β: the good, the bad and the ugly. J. Exp. Med. 180:1587-1590.
16. Letterio, J.J., and Roberts, A.B. 1998. Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 16:137-161.
17. Grimm, M.C., et al. 1995. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J. Gastroenterol. Hepatol. 10:387-395.
18. Burgio, V.T., Fais, S., Boirivant, M.. Perrone, A., and Pallone, F. 1995. Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. Gastroenterology. 109:1029-1038.
19. Li, L., Meng, G., Graham, M.F., Shaw, G.M., and Smith, P.D. 1999. Intestinal macrophages display reduced permissiveness to human immunodeficiency virus 1 and decreased surface CCR5. Gastroenterology. 116:1043-1053.
20. Meng, G., et al. 2000. Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are likely target cell for human immunodeficiency virus type 1 in the intestinal mucosa. J. Infect. Dis. 182:785-791.
21. Savill, J., Hogg, N., Ren, Y., and Haslett, C. 1992. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 90:1513-1522.
22. McCartney-Francis, N., Mizel, D., Wong, H., Wahl, L., and Wahl, S. 1990. TGF-β regulates production of growth factors and TGF-β by human peripheral blood monocytes. Growth Factors. 4:27-35.
23. Blobe, G.C., Schiemann, W.P., and Lodish, H.F. 2000. Role of transforming growth factor β in human disease. N. Engl. J. Med. 342:1350-1358.
24. Barnard, J.A., Beauchamp, R.D., Coffey, R.J., and Moses, H.L. 1989. Regulation of intestinal epithelial cell growth by transforming growth factor type β. Proc. Natl. Acad. Sci. U. S. A. 86:1578-1582.
25. Suemori, S., Ciacci, C., and Podolsky, D.K. 1991. Regulation of transforming growth factor expression in rat intestinal epithelial cell lines. J. Clin. Invest. 87:2216-2221.
26. Ashcroft, G.S., et al. 2000. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat. Med. 6:1147-1153.
27. Saharinen, J., Hyytiäinen, M., Taipale, J., and Keski-Oja, J. 1999. Latent transforming growth factor-β binding proteins (LTBPs) - structural extracellular matrix proteins for targeting TGF-β action. Cytokine Growth Factor Rev. 10:99-117.
28. Shull, M.M., et al. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 359:693-699.
29. Fiorentino, D.F., Zlotnik, A., Mosmann, T.R., Howard, M., and O'Garra, A. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3822.
30. Schottelius, A.J., Mayo, M.W., Sartor, R.B., and Baldwin, A.S.J. 1999. Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding. J. Biol. Chem. 274:31868-31874.
31. Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., and Müller, W. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:263-274.
32. Herfarth, H.H., Mohanty, S.P., Rath, H.C., Tonkonogy, S., and Sartor, R.B. 1996. Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers. Gut. 39:836-845.
33. Graham, M.F., Bryson, G.R., and Diegelmann, R.F. 1990. Transforming growth factor beta 1 selectively augments collagen synthesis by human intestinal smooth muscle cells. Gastroenterology. 99:447-453.
34. Babyatsky, M.W., Rossiter, G., and Podolsky, D.K. 1996. Expression of transforming growth factors α and β in colonic mucosa in inflammatory bowel disease. Gastroenterology. 110:975-984.
35. Arsura, M., Wu, M., and Sonenshein, G.E. 1996. TGFβ1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: transcriptional activation of IκBα. Immunity. 5:31-40.
36. Powell, P.P., Dixon, L.K., and Parkhouse, R.M.E. 1996. An IκB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages. J. Virol. 70:8527-8533.
37. Soumelis, V., et al. 2002. Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nat. Immunol. 3:673-680.
38. Bondeson, J., Browne, K.A., Brennan, F.M., Foxwell, B.M.J., and Feldmann, M. 1999. Selective regulation of cytokine induction by adenoviral gene transfer of IκBα into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-κB independent. J. Immunol. 162:2939-2945.
39. Rugtveit, J., et al. 1997. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology. 112:1493-1505.
40. Wahl, L.M., and Smith, P.D. 1991. Isolation of macrophages/monocytes from human peripheral blood and tissues. In Current protocols in immunology. J.E. Coligan, A.M. Kruisbeek, D.H. Marguilies, E.M. Shevach, and W. Strober, editors. John Wiley & Sons Inc. New York, New York, USA. 7.6.1-7.6.8.
41. Redman, T.K., Britt, W.J., Wilcox, C.M., Graham, M.F., and Smith, P.D. 2002. Human cytomegalovirus enhances chemokine production by lipopolysaccharide-stimulated lamina propria macrophages. J. Infect. Dis. 185:584-590.
42. + dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 93:2588-2592.
43. + cells. Nat. Med. 8:150-156.
44. Monteyne, P., Guillaume, B., and Sindic, C.J.M. 1998. BB7-1 (CD80), B7-2 (CD86), interleukin-12 and transforming growth factor-β mRNA expression in CSF and peripheral blood mononuclear cells from multiple sclerosis patients. J. Neuroimmunol. 91:198-203.